Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cutan Med Surg ; 5(6): 479-85, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11907856

RESUMO

BACKGROUND: Pseudoporphyria has been attributed to both medication usage and chronic hemodialysis. Histologically, it is identical to porphyria cutanea tarda. It is most commonly seen as localized bullae on sun-exposed skin, often on the dorsum of the hands and fingers. OBJECTIVES: We describe a 31-year-old man with rapidly evolving bullae which became denuded, clinically suggestive of toxic epidermal necrolysis. Pseudoporphyria was proven histologically. However, our patient's eruption was not localized as small bullae but was widespread, with large bullae evolving into large, cutaneous, denuded erosions. CONCLUSIONS: We describe a previously unreported, generalized variant of pseudoporphyria that resembles toxic epidermal necrolysis. We provide a review of pseudoporphyria and compare our variant to toxic epidermal necrolysis and mimicking disorders.


Assuntos
Porfirias/patologia , Síndrome de Stevens-Johnson/patologia , Adulto , Diagnóstico Diferencial , Humanos , Masculino
3.
Am J Med Sci ; 303(1): 9-15, 1992 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-1728876

RESUMO

This study was designed to compare the clinical efficacy and safety of oral clonidine and oral labetalol in the treatment of severe hypertension in an emergency department setting. Thirty-six patients with severely elevated blood pressure (mean baseline blood pressure 199/132 mm Hg) without acute end-organ dysfunction were treated with either oral labetalol or oral clonidine in a randomized double-blind prospective study. Labetalol was administered as an initial dose of 200 mg, followed by hourly 200 mg doses up to 1,200 mg. Clonidine was administered as an initial dose of 0.2 mg, followed by hourly 0.1 mg doses up to 0.7 mg. Labetalol reduced diastolic blood pressure in 94% of the patients within 6 hours, with a mean reduction in blood pressure of 54/37 mm Hg. Clonidine reduced diastolic blood pressure in 83% of the patients within 6 hours, with a mean reduction in blood pressure of 57/32 mm Hg. The authors conclude that oral labetalol was comparable to clonidine in efficacy, had a similar incidence of side effects, and offered the clinician a useful alternative for the treatment of severe hypertension in an emergency department setting. Further studies are indicated to determine appropriate dosing regimens for oral labetalol in the acute treatment of severe hypertension.


Assuntos
Clonidina/uso terapêutico , Emergências , Hipertensão/tratamento farmacológico , Labetalol/uso terapêutico , Administração Oral , Pressão Sanguínea/efeitos dos fármacos , Clonidina/administração & dosagem , Diástole/efeitos dos fármacos , Feminino , Frequência Cardíaca/efeitos dos fármacos , Humanos , Hipertensão/fisiopatologia , Labetalol/administração & dosagem , Masculino , Pessoa de Meia-Idade , Sístole/efeitos dos fármacos , Fatores de Tempo
4.
Ann Intern Med ; 114(12): 1020-4, 1991 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-2029097

RESUMO

OBJECTIVE: To evaluate the accuracy of fingerstick glucose measurements in severely hypotensive patients. DESIGN: Prospective, nonrandomized comparison study. SETTING: Emergency department in a university hospital. PATIENTS: Twenty-five severely hypotensive patients (systolic blood pressure less than or equal to 80 mm Hg) and 39 normotensive patients. MEASUREMENTS: Simultaneous fingerstick reagent strip glucose, venous reagent strip glucose, and laboratory glucose values were compared. Data were analyzed using error-grid analysis. RESULTS: In hypotensive patients, the mean fingerstick glucose values were significantly lower than the values obtained either by venous reagent strip or laboratory glucose measurements. Fingerstick glucose values in the hypotensive group were 67.5% of laboratory glucose values, and were significantly lower than the values obtained in the normotensive group (91.8%, P less than 0.001). Only 36% of the hypotensive patients had fingerstick glucose values within the acceptable range of 20% of the laboratory glucose value. Thirty-two percent of hypotensive patients were incorrectly diagnosed as hypoglycemic (glucose less than 3.89 mmol/L [70 mg/dL]); 2 of these patients were actually hyperglycemic (glucose greater than 11.10 mmol/L [200 mg/dL]). Venous reagent strip measurements accurately reflected laboratory glucose values in both hypotensive and normotensive patients. CONCLUSIONS: Fingerstick glucose testing does not accurately represent venous glucose levels in severely hypotensive patients. If fingerstick glucose testing is relied on for these patients, errors in clinical management may be made. Venous reagent strip glucose testing correlates well with laboratory glucose measurements and should be the preferred method for rapid assessment of glucose level in critically ill patients with severe hypotension.


Assuntos
Glicemia/análise , Coleta de Amostras Sanguíneas/métodos , Choque/sangue , Capilares , Estudos de Avaliação como Assunto , Humanos , Hipotensão/sangue , Estudos Prospectivos , Fitas Reagentes , Padrões de Referência , Estatística como Assunto , Veias
5.
Ann Emerg Med ; 19(11): 1335-7, 1990 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-2240735

RESUMO

Severe hypothermia with cardiopulmonary arrest often requires prolonged resuscitation while rewarming procedures are implemented. A 63-year-old male in cardiopulmonary arrest with a core body temperature of 23.7 C was resuscitated successfully after core rewarming by means of a two-chest-tube continuous thoracostomy lavage procedure. This lavage procedure resulted in effective and rapid rewarming after other conventional rewarming methods had failed.


Assuntos
Parada Cardíaca/etiologia , Temperatura Alta/uso terapêutico , Hipotermia/terapia , Ressuscitação/métodos , Irrigação Terapêutica/métodos , Toracostomia , Temperatura Corporal , Parada Cardíaca/terapia , Humanos , Hipotermia/complicações , Hipotermia/fisiopatologia , Masculino , Pessoa de Meia-Idade , Cloreto de Sódio/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...